Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C

Am J Gastroenterol. 2016 May;111(5):744-5. doi: 10.1038/ajg.2016.39.

Authors

Rafael Stern¹, Stephanie Hametner², Al-Zoairy Ramona³, Stephan Moser⁴, Asia Karpi⁴, Hermann Laferl⁵, Rudolf E Stauber⁶, Heinz M Zoller³, Andreas Maieron², Wolfgang Vogel³, Ivo Graziadei⁷, Michael Gschwantler⁴, Karin Kozbial¹, Clarissa Freissmuth¹, Harald Hofer¹, Peter Ferenci¹

Affiliations

¹ Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
² Department of Gastroenterology, Elisabethinen Hospital, Linz, Austria.
³ Department of Medicine II, Gastroenterology and Hepatology, Medical University of Innsbruck, Innsbruck, Austria.
⁴ Department of Medicine IV, Wilheminen Hospital, Vienna, Austria.
⁵ Department of Internal Medicine, Kaiser-Franz-Josef Hospital, Vienna, Austria.
⁶ Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical Universitiy of Graz, Graz, Austria.
⁷ Department of Internal Medicine, Krankenhaus Hall, Hall, Austria.

PMID: 27151123
DOI: 10.1038/ajg.2016.39

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antiviral Agents / therapeutic use*
Benzimidazoles / therapeutic use*
Carbamates
Drug Therapy, Combination
Fatigue / chemically induced
Female
Fluorenes / therapeutic use*
Hepatitis C, Chronic / drug therapy*
Humans
Imidazoles / therapeutic use*
Male
Pruritus / chemically induced
Pyrrolidines
Recurrence
Simeprevir / therapeutic use*
Sleep Initiation and Maintenance Disorders / chemically induced
Sofosbuvir / therapeutic use*
Sustained Virologic Response
Treatment Outcome
Valine / analogs & derivatives

Substances

Antiviral Agents
Benzimidazoles
Carbamates
Fluorenes
Imidazoles
Pyrrolidines
ledipasvir
Simeprevir
Valine
daclatasvir
Sofosbuvir